Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression

被引:20
|
作者
Petrus, Paul [1 ]
Rosqvist, Fredrik [2 ]
Edholm, David [3 ]
Mejhert, Niklas [1 ]
Arner, Peter [1 ]
Dahlman, Ingrid [1 ]
Ryden, Mikael [1 ]
Sundbom, Magnus [3 ]
Riserus, Ulf [2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden
[3] Uppsala Univ, Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
11-beta-hsd1; Saturated fatty acids; Gene expression; Adipose tissue; Visceral fat; Cortisol; Diet; POLYUNSATURATED FAT; OBESITY; INSULIN; HEALTH; LIVER;
D O I
10.1186/s12944-015-0042-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Visceral fat accumulation is associated with metabolic disease. It is therefore relevant to study factors that regulate adipose tissue distribution. Recent data shows that overeating saturated fatty acids promotes greater visceral fat storage than overeating unsaturated fatty acids. Visceral adiposity is observed in states of hypercortisolism, and the enzyme 11-beta-hydroxysteroid-dehydrogenase type 1 (11 beta-hsd1) is a major regulator of cortisol activity by converting inactive cortisone to cortisol in adipose tissue. We hypothesized that tissue fatty acid composition regulates body fat distribution through local effects on the expression of 11 beta-hsd1 and its corresponding gene (HSD11B1) resulting in altered cortisol activity. Findings: Visceral- and subcutaneous adipose tissue biopsies were collected during Roux-en-Y gastric bypass surgery from 45 obese women (BMI; 41 +/- 4 kg/m(2)). The fatty acid composition of each biopsy was measured and correlated to the mRNA levels of HSD11B1. 11 beta-hsd1 protein levels were determined in a subgroup (n = 12) by western blot analysis. Our main finding was that tissue saturated fatty acids (e.g. palmitate) were associated with increased 11 beta-hsd1 gene- and protein-expression in visceral but not subcutaneous adipose tissue. Conclusions: The present study proposes a link between HSD11B1 and saturated fatty acids in visceral, but not subcutaneous adipose tissue. Nutritional regulation of visceral fat mass through HSD11B1 is of interest for the modulation of metabolic risk and warrants further investigation.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients
    Baudrand, Rene
    Miguel Dominguez, Jose
    Carvajal, Cristian A.
    Riquelme, Arnoldo
    Campino, Carmen
    Macchiavello, Stefano
    Bozinovic, Milan
    Morales, Mauricio
    Pizarro, Margarita
    Solis, Nancy
    Escalona, Alex
    Boza, Camilo
    Arrese, Marco
    Fardella, Carlos E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (12): : 1775 - 1780
  • [22] Central Glucocorticoid Administration Promotes Weight Gain and Increased 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in White Adipose Tissue
    Veyrat-Durebex, Christelle
    Deblon, Nicolas
    Caillon, Aurelie
    Andrew, Ruth
    Altirriba, Jordi
    Odermatt, Alex
    Rohner-Jeanrenaud, Francoise
    PLOS ONE, 2012, 7 (03):
  • [23] Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue:: Tissue-specific induction by cytokines
    Tomlinson, JW
    Moore, J
    Cooper, MS
    Bujalska, I
    Shahmanesh, M
    Burt, C
    Strain, A
    Hewison, M
    Stewart, PM
    ENDOCRINOLOGY, 2001, 142 (05) : 1982 - 1989
  • [24] NASH with pericentral fibrosis and neutrophil inflammation in mice overexpressing 11α-hydroxysteroid-dehydrogenase (HSD-1) in adipose tissue
    Popov, Y.
    Mueller, S.
    Turner, B.
    Zinkin, N.
    Nasser, I.
    Masuzaki, H.
    Viereck, J.
    Hamilton, J.
    Flier, J.
    Afdhal, N.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S260 - S260
  • [25] Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone
    Sandeep, TC
    Andrew, R
    Homer, NZM
    Andrews, RC
    Smith, K
    Walker, BR
    DIABETES, 2005, 54 (03) : 872 - 879
  • [26] Rosiglitazone decreases 11β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
    Mai, Knut
    Andres, Janin
    Bobbert, Thomas
    Maser-Gluth, Christiane
    Moehlig, Matthias
    Baehr, Volker
    Pfeiffer, Andreas F. H.
    Spranger, Joachim
    Diederich, Sven
    CLINICAL ENDOCRINOLOGY, 2007, 67 (03) : 419 - 425
  • [27] Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue
    Prasad, Sakamuri S. S. Vara
    Kumar, Shanmugam S. Jeya
    Kumar, Putcha Uday
    Qadri, Syed S. Y. H.
    Vajreswari, Ayyalasomayajula
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [28] Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue
    Sakamuri SS Vara Prasad
    Shanmugam S Jeya Kumar
    Putcha Uday Kumar
    Syed SYH Qadri
    Ayyalasomayajula Vajreswari
    Lipids in Health and Disease, 9
  • [29] Recent progress in 11-β-hydroxysteroid dehydrogenase type 1 (11-β-HSD1) inhibitor development
    Barf, Tjeerd
    Williams, Meredith
    DRUGS OF THE FUTURE, 2006, 31 (03) : 231 - 243
  • [30] Expression and functional consequences of 11-β-hydroxysteroid dehydrogenase activity in human bone
    Cooper, MS
    Walker, EA
    Bland, R
    Fraser, WD
    Hewison, M
    Stewart, PM
    BONE, 2000, 27 (03) : 375 - 381